As of 2026-03-23, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is (145.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.71 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -924.2%.
The range of the Relative Valuation is (133.90) - (162.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 23.8x | 21.7x |
| Forward P/E multiples | 19.7x - 24.4x | 21.2x |
| Fair Price | (133.90) - (162.04) | (145.96) |
| Upside | -856.1% - -1015.0% | -924.2% |
| Date | P/E |
| 2026-03-20 | -2.46 |
| 2026-03-19 | -2.45 |
| 2026-03-18 | -2.52 |
| 2026-03-17 | -2.48 |
| 2026-03-16 | -2.45 |
| 2026-03-13 | -2.41 |
| 2026-03-12 | -2.51 |
| 2026-03-11 | -2.59 |
| 2026-03-10 | -2.60 |
| 2026-03-09 | -2.60 |
| 2026-03-06 | -2.46 |
| 2026-03-05 | -2.39 |
| 2026-03-04 | -2.37 |
| 2026-03-03 | -2.33 |
| 2026-03-02 | -2.40 |
| 2026-02-27 | -2.47 |
| 2026-02-26 | -2.57 |
| 2026-02-25 | -2.79 |
| 2026-02-24 | -2.77 |
| 2026-02-23 | -2.67 |
| 2026-02-20 | -2.78 |
| 2026-02-19 | -2.74 |
| 2026-02-18 | -2.70 |
| 2026-02-17 | -2.63 |
| 2026-02-13 | -2.62 |
| 2026-02-12 | -2.56 |
| 2026-02-11 | -2.64 |
| 2026-02-10 | -2.70 |
| 2026-02-09 | -2.69 |
| 2026-02-06 | -2.72 |
| 2026-02-05 | -2.51 |
| 2026-02-04 | -2.90 |
| 2026-02-03 | -2.98 |
| 2026-02-02 | -3.05 |
| 2026-01-30 | -2.99 |
| 2026-01-29 | -3.12 |
| 2026-01-28 | -3.14 |
| 2026-01-27 | -3.26 |
| 2026-01-26 | -3.35 |
| 2026-01-23 | -3.11 |
| 2026-01-22 | -3.21 |
| 2026-01-21 | -3.14 |
| 2026-01-20 | -3.10 |
| 2026-01-16 | -3.11 |
| 2026-01-15 | -3.14 |
| 2026-01-14 | -3.35 |
| 2026-01-13 | -3.16 |
| 2026-01-12 | -3.11 |
| 2026-01-09 | -3.51 |
| 2026-01-08 | -3.41 |